Association Between the Occurrence and Spectrum of Immune-Related Adverse Events and Efficacy of Pembrolizumab in Asian Patients With Advanced Urothelial Cancer: Multicenter Retrospective Analyses and Systematic Literature Review
Toshiki Kijima, Hiroshi Fukushima, Shota Kusuhara, Hajime Tanaka, Soichiro Yoshida, Minato Yokoyama, Junichiro Ishioka, Yoh Matsuoka, Noboru Numao, Yasuyuki Sakai, Kazutaka Saito, Nobuaki Matsubara, Takeshi Yuasa, Hitoshi Masuda, Junji Yonese, Yukio Kageyama, Yasuhisa Fujii
Topics & Concepts
MedicinePembrolizumabCommon Terminology Criteria for Adverse EventsAdverse effectInternal medicineOncologyRetrospective cohort studyCancerImmunotherapyCancer Immunotherapy and BiomarkersBladder and Urothelial Cancer TreatmentsFerroptosis and cancer prognosis